Natural history of chronic hepatitis B virus infection

[1]  R. Thimme,et al.  Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation. , 2014, Journal of hepatology.

[2]  G. Raimondo,et al.  Occult hepatitis B infection. , 2014, Journal of hepatology.

[3]  E. Sagnelli,et al.  Clinical impact of occult hepatitis B virus infection in immunosuppressed patients. , 2014, World journal of hepatology.

[4]  M. Fälth,et al.  Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes. , 2014, Gastroenterology.

[5]  S. Locarnini,et al.  Possible origins and evolution of the hepatitis B virus (HBV). , 2013, Seminars in cancer biology.

[6]  O. Shibolet,et al.  Immunosuppression and HBV Reactivation , 2013, Seminars in Liver Disease.

[7]  J. Brosius,et al.  The genome of a Mesozoic paleovirus reveals the evolution of hepatitis B viruses , 2013, Nature Communications.

[8]  S. Ho,et al.  Dating the origin and dispersal of hepatitis B virus infection in humans and primates , 2013, Hepatology.

[9]  M. Maini,et al.  NK Cells: A Double-Edged Sword in Chronic Hepatitis B Virus Infection , 2013, Front. Immunol..

[10]  G. Reynolds,et al.  Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell–mediated deletion , 2013, The Journal of experimental medicine.

[11]  M. Çiriş,et al.  Cytokine levels and histopathology in chronic hepatitis B and chronic hepatitis C. , 2012, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[12]  Wenhui Li,et al.  Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus , 2012, eLife.

[13]  O. Pappo,et al.  Tracing hepatitis B virus to the 16th century in a Korean mummy , 2012, Hepatology.

[14]  A. Boonstra,et al.  Hepatitis B virus suppresses the functional interaction between natural killer cells and plasmacytoid dendritic cells , 2012, Journal of viral hepatitis.

[15]  R. Welsh,et al.  Natural killer cells act as rheostats modulating antiviral T cells , 2011, Nature.

[16]  T. Mak,et al.  Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity , 2011, Proceedings of the National Academy of Sciences.

[17]  A. Bertoletti,et al.  Republished: Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection , 2011, Postgraduate Medical Journal.

[18]  E John Wherry,et al.  T cell exhaustion , 2011 .

[19]  H. Blum,et al.  HBV life cycle and novel drug targets , 2011, Hepatology international.

[20]  Y. S. Hahn,et al.  Regulation of NK cell repertoire and function in the liver. , 2011, Critical reviews in immunology.

[21]  B. Stieger.  The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation. , 2011, Handbook of experimental pharmacology.

[22]  M. Maini,et al.  Blockade of Immunosuppressive Cytokines Restores NK Cell Antiviral Function in Chronic Hepatitis B Virus Infection , 2010, PLoS pathogens.

[23]  C. Feschotte,et al.  Genomic Fossils Calibrate the Long-Term Evolution of Hepadnaviruses , 2010, PLoS biology.

[24]  W. Gerlich,et al.  Occult Hepatitis B Virus Infection: Detection and Significance , 2010, Digestive Diseases.

[25]  Michael G Brown,et al.  Intrahepatic IL-10 Maintains NKG2A+Ly49− Liver NK Cells in a Functionally Hyporesponsive State , 2010, The Journal of Immunology.

[26]  M. Dandri,et al.  The replication cycle of hepatitis B virus. , 2010, Journal of hepatology.

[27]  F. Chisari,et al.  Immune effectors required for hepatitis B virus clearance , 2009, Proceedings of the National Academy of Sciences.

[28]  C. Hourioux,et al.  Morphogenesis of hepatitis B virus and its subviral envelope particles , 2009, Cellular microbiology.

[29]  P. Klenerman,et al.  Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. , 2009, Gastroenterology.

[30]  G. Michelone,et al.  Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. , 2009, Gastroenterology.

[31]  Pratip K. Chattopadhyay,et al.  The Size of the Viral Inoculum Contributes to the Outcome of Hepatitis B Virus Infection , 2009, Journal of Virology.

[32]  M. Buendia,et al.  Statements from the Taormina expert meeting on occult hepatitis B virus infection. , 2008, Journal of hepatology.

[33]  G. Alexander,et al.  Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection , 2008, The Journal of experimental medicine.

[34]  D. Hasenclever,et al.  Should Treatment of Hepatitis B Depend on Hepatitis B virus Genotypes? A Hypothesis Generated from an Explorative Analysis of Published Evidence , 2008, Antiviral therapy.

[35]  R. Pierce,et al.  TLR-dependent cross talk between human Kupffer cells and NK cells , 2008, The Journal of experimental medicine.

[36]  G. Fattovich,et al.  Epidemiology and natural history of hepatitis B , 2008 .

[37]  G. Freeman,et al.  PD-1 expression on human CD8 T cells depends on both state of differentiation and activation status , 2007, AIDS.

[38]  S. Yuen,et al.  Natural history and disease progression in Chinese chronic hepatitis B patients in immune‐tolerant phase , 2007, Hepatology.

[39]  E. Wherry,et al.  IL-10, T cell exhaustion and viral persistence. , 2007, Trends in microbiology.

[40]  J. Hoofnagle,et al.  Management of hepatitis B: Summary of a clinical research workshop , 2007, Hepatology.

[41]  M. Kann,et al.  Intracellular transport of hepatitis B virus. , 2007, World journal of gastroenterology.

[42]  S. Urban,et al.  Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans. , 2007, Hepatology.

[43]  W. Haining,et al.  Resolution of a chronic viral infection after interleukin-10 receptor blockade , 2006, The Journal of experimental medicine.

[44]  L. Teyton,et al.  Interleukin-10 determines viral clearance or persistence in vivo , 2006, Nature Medicine.

[45]  L. Ye,et al.  Pathogenesis of hepatitis B virus infection , 2006 .

[46]  R. Sun,et al.  Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. , 2006, Gastroenterology.

[47]  H. Janssen,et al.  Treatment with Peg-Interferon α-2b for HBeAg-Positive Chronic Hepatitis B: HBsAg Loss Is Associated with HBV Genotype , 2006, The American Journal of Gastroenterology.

[48]  A. Lok,et al.  Natural history of chronic hepatitis B virus infection: What we knew in 1981 and what we know in 2005 , 2006, Hepatology.

[49]  L. Peyrin-Biroulet,et al.  [Epidemiology and natural history of hepatitis C]. , 2005, La Revue du praticien.

[50]  R. Gish,et al.  HBV core sequence: definition of genotype‐specific variability and correlation with geographical origin , 2004, Journal of viral hepatitis.

[51]  P. Coursaget,et al.  Genetic Diversity of Hepatitis B Virus Strains Derived Worldwide: Genotypes, Subgenotypes, and HBsAg Subtypes , 2004, Intervirology.

[52]  F. Miselli,et al.  Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years. , 2004, Gastroenterology.

[53]  Geoffrey Dusheiko,et al.  Longitudinal Analysis of CD8+ T Cells Specific for Structural and Nonstructural Hepatitis B Virus Proteins in Patients with Chronic Hepatitis B: Implications for Immunotherapy , 2004, Journal of Virology.

[54]  D. Ganem,et al.  Hepatitis B virus infection--natural history and clinical consequences. , 2004, The New England journal of medicine.

[55]  B. McMahon,et al.  The Natural History of Chronic Hepatitis B Virus Infection , 2004, Seminars in liver disease.

[56]  R. Purcell,et al.  Genomic analysis of the host response to hepatitis B virus infection. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[57]  D. Milich,et al.  Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection , 2003, Hepatology.

[58]  M. Smyth,et al.  Functional interactions between dendritic cells and NK cells during viral infection , 2003, Nature Immunology.

[59]  R. Purcell,et al.  CD8+ T Cells Mediate Viral Clearance and Disease Pathogenesis during Acute Hepatitis B Virus Infection , 2003, Journal of Virology.

[60]  Ruy M Ribeiro,et al.  Dynamics of hepatitis B virus infection. , 2002, Microbes and infection.

[61]  C. Chu,et al.  Precore Stop Mutant in HBeAg-Positive Patients with Chronic Hepatitis B: Clinical Characteristics and Correlation with the Course of HBeAg-to-Anti-HBe Seroconversion , 2002, Journal of Clinical Microbiology.

[62]  B. McMahon,et al.  Serologic and Clinical Outcomes of 1536 Alaska Natives Chronically Infected with Hepatitis B Virus , 2001, Annals of Internal Medicine.

[63]  D. Vergani,et al.  Incubation phase of acute hepatitis B in man: Dynamic of cellular immune mechanisms , 2000, Hepatology.

[64]  C. Seeger,et al.  Hepatitis B Virus Biology , 2000, Microbiology and Molecular Biology Reviews.

[65]  B. Hartmann,et al.  Virus-specific lymphokine production differs quantitatively but not qualitatively in acute and chronic hepatitis B infection. , 1999, Virology.

[66]  M. Lai,et al.  Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. , 1997, The New England journal of medicine.

[67]  H. Hsu,et al.  Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan. , 1996, JAMA.

[68]  B. Moss,et al.  The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis , 1995, The Journal of experimental medicine.

[69]  E. Christensen,et al.  Occurrence of hepatocellular carcinoma and decompensation in western european patients with cirrhosis type B , 1995, Hepatology.

[70]  P. Meier,et al.  In situ localization of the hepatocytic Na+/Taurocholate cotransporting polypeptide in rat liver. , 1994, Gastroenterology.

[71]  J. Cullen,et al.  Woodchuck hepatitis virus infections: very rapid recovery after a prolonged viremia and infection of virtually every hepatocyte , 1994, Journal of virology.

[72]  J. Pollack,et al.  Site-specific RNA binding by a hepatitis B virus reverse transcriptase initiates two distinct reactions: RNA packaging and DNA synthesis , 1994, Journal of virology.

[73]  F. Zoulim,et al.  Woodchuck hepatitis virus X protein is required for viral infection in vivo , 1994, Journal of virology.

[74]  P. Meier,et al.  Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/bile acid cotransporter. , 1994, The Journal of clinical investigation.

[75]  I. Mushahwar,et al.  Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variations in the primary structure of the surface antigen. , 1993, The Journal of general virology.

[76]  R. Purcell,et al.  The precore gene of the woodchuck hepatitis virus genome is not essential for viral replication in the natural host , 1992, Journal of virology.

[77]  D. Ganem,et al.  Assembly of hepadnaviral virions and subviral particles. , 1991, Current topics in microbiology and immunology.

[78]  A Valli,et al.  Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. , 1990, Journal of immunology.

[79]  F Tsuda,et al.  Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen , 1990, Journal of virology.

[80]  R. Beasley.  Hepatitis B virus. The major etiology of hepatocellular carcinoma , 1988, Cancer.

[81]  H. Varmus,et al.  Expression of the precore region of an avian hepatitis B virus is not required for viral replication , 1987, Journal of virology.

[82]  A. Lok,et al.  Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection. , 1987, Gastroenterology.

[83]  J. Summers,et al.  Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells , 1986, Cell.

[84]  B. Moss,et al.  Live recombinant vaccinia virus protects chimpanzees against hepatitis B , 1984, Nature.

[85]  M. Imai,et al.  Immunochemical structure of hepatitis B e antigen in the serum. , 1983, Journal of immunology.

[86]  Conn Nk,et al.  Letter: Avirulent corynebacteria. , 1975 .

[87]  D. S. Dane,et al.  Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. , 1970, Lancet.